All In Biotech

Drug Trial Radar · NCT05718817

An Open-label Study of XEN1101 in Epilepsy

A Multicenter, Open-label, Long-term, Safety, Tolerability, and Efficacy Study of XEN1101 in Subjects Diagnosed With Epilepsy

Last checked: Nov 19, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitationPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Enrolling by invitation

Enrollment

880

Planned (sponsor's estimate)

Start

Apr 25, 2023

Primary completion

Apr 2033

Study completion Jun 2033

Sponsor

Lead sponsor
Xenon Pharmaceuticals Inc.Industry
Sponsor type
Industry
Collaborators
Worldwide Clinical Trials
First posted
Feb 8, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate the long term safety, tolerability, pharmacokinetics (PK), and efficacy of XEN1101 in subjects with Focal Onset Seizures (FOS) or Primary Generalized Tonic-Clonic Seizures (PGTCS) for the treatment of seizures for up to 6 years.

Conditions

  • Focal Epilepsy
  • Tonic-Clonic Seizures

Interventions

  • XEN1101Drug

    XEN1101 capsules

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The adverse eventsTime frame: From the start of treatment in the open-label extension (OLE) study through 8 weeks after the last dose.

Locations

153 sites in 25 countries. Site status is shown where the registry gives one.

  • Xenoscience

    Phoenix, Arizona

  • University of Arizona - Health Sciences

    Tucson, Arizona

  • Clinical Trials, Inc

    Little Rock, Arkansas

  • Brain Science Research Institute

    Los Angeles, California

  • UC Irvine Health

    Orange, California

  • University of California, Davis Clinical & Translational Science Center Clinical Research (CCRC)

    Sacramento, California

  • University of Colorado Hospital Anschutz Outpatient Pavilion

    Aurora, Colorado

  • Mayo Clinic Florida

    Jacksonville, Florida

  • Serenity Research Center, LLC

    Miami, Florida

  • Research Institute of Orlando, LLC

    Orlando, Florida

  • Panhandle Research & Medical Clinic

    Pensacola, Florida

  • University of South Florida

    Tampa, Florida

  • Encore Medical Research of Weston, LLC

    Weston, Florida

  • Hawaii Pacific Neuroscience

    Honolulu, Hawaii

  • Consultants in Epilepsy and Neurology

    Boise, Idaho

  • Indiana University School of Medicine

    Indianapolis, Indiana

  • The University of Kansas Medical Center

    Kansas City, Kansas

  • Bluegrass Epilepsy Research, LLC

    Lexington, Kentucky

  • Kentucky Clinic

    Lexington, Kentucky

  • MMP Neurology

    Scarborough, Maine

  • University of Maryland Medical Center

    Baltimore, Maryland

  • Mid-Atlantic Epilepsy and Sleep Center

    Bethesda, Maryland

  • Brigham and Women's Hospital

    Boston, Massachusetts

  • UMass Chan Medical School

    Worcester, Massachusetts

  • University of Michigan Hospitals

    Ann Arbor, Michigan

  • Wayne State University

    Detroit, Michigan

  • Michigan State University

    East Lansing, Michigan

  • Cornwell Health (Spectrum Health Hospitals)

    Grand Rapids, Michigan

  • Minneapolis Clinic of Neurology

    Burnsville, Minnesota

  • Saint Louis University Medical School

    St Louis, Missouri

  • Northeast Epilepsy Group

    Hackensack, New Jersey

  • Dent Neurosciences Research Center

    Buffalo, New York

  • New York University Comprehensive Epilepsy Center

    New York, New York

  • Mount Sinai Health

    New York, New York

  • SUNY Upstate Medical University

    Syracuse, New York

  • Montefiiore Medical Center

    The Bronx, New York

  • Onsite Clinical Solutions

    Charlotte, North Carolina

  • Duke University

    Durham, North Carolina

  • Meridian Clinical Research, LLC

    Raleigh, North Carolina

  • Summa Health

    Akron, Ohio

Showing 40 of 153 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.